Parallel Advisors, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 193 filers reported holding NEKTAR THERAPEUTICS in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$9,422
+3.5%
15,8200.0%0.00%
Q2 2023$9,100
-18.2%
15,8200.0%0.00%
Q1 2023$11,120
-70.7%
15,820
-5.9%
0.00%
-100.0%
Q4 2022$37,997
-33.3%
16,813
-6.2%
0.00%
-33.3%
Q3 2022$57,000
-14.9%
17,916
+1.3%
0.00%0.0%
Q2 2022$67,000
-28.7%
17,678
+4.3%
0.00%
-25.0%
Q1 2022$94,000
-60.3%
16,943
-3.3%
0.00%
-55.6%
Q4 2021$237,000
-23.1%
17,523
+2.0%
0.01%
-25.0%
Q3 2021$308,000
+6.9%
17,173
+2.2%
0.01%0.0%
Q2 2021$288,000
-14.5%
16,796
-0.3%
0.01%
-25.0%
Q1 2021$337,000
+18.2%
16,840
+0.3%
0.02%
+6.7%
Q4 2020$285,0000.0%16,782
-2.4%
0.02%
-16.7%
Q3 2020$285,000
-22.8%
17,187
+7.7%
0.02%
-25.0%
Q2 2020$369,000
+29.5%
15,955
-0.3%
0.02%
+4.3%
Q1 2020$285,000
-16.2%
16,000
+1.7%
0.02%
-11.5%
Q4 2019$340,000
+19.3%
15,735
+0.5%
0.03%
+8.3%
Q3 2019$285,000
-48.8%
15,6590.0%0.02%
-55.6%
Q2 2019$557,000
+6.3%
15,659
+0.4%
0.05%
-8.5%
Q1 2019$524,000
+2.3%
15,6000.0%0.06%
-16.9%
Q4 2018$512,000
-46.2%
15,6000.0%0.07%
-39.8%
Q3 2018$951,000
+24.6%
15,600
-0.2%
0.12%
+8.3%
Q2 2018$763,000
-53.8%
15,635
+0.5%
0.11%
-57.8%
Q1 2018$1,652,00015,5500.26%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2023
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 508,000$6,132,0001.80%
Bodri Capital Management, LLC 250,000$3,018,0001.46%
Granahan Investment Management 3,442,980$41,557,0001.28%
TIRSCHWELL & LOEWY INC 603,441$7,284,0001.22%
NEA Management Company, LLC 1,825,600$22,035,0001.12%
Cormorant Asset Management, LP 450,000$5,432,0001.12%
HARVEY CAPITAL MANAGEMENT INC 221,750$2,676,0001.05%
Cheyne Capital Management (UK) LLP 229,577$2,772,0000.99%
Artal Group S.A. 1,650,000$19,916,0000.73%
FIC CAPITAL INC 147,293$1,778,0000.71%
View complete list of NEKTAR THERAPEUTICS shareholders